Skip to main content
Abbott Laboratories (Pakistan) Limited logo

Abbott Laboratories (Pakistan) Limited — Investor Relations & Filings

Listed
Ticker · ABOT ISIN · PK0025701019 LEI · 549300BL6LRIQC5XXV35 PSX Manufacturing
Open in API
Filings indexed 187 across all filing types
Latest filing 2026-06-10 Board/Management Inform…
Country PK Pakistan
Listing PSX ABOT · 1 venue

About Abbott Laboratories (Pakistan) Limited

https://www.pk.abbott/homepage.html

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets a diverse portfolio of healthcare products. Its core activities encompass research-based pharmaceuticals, nutritional products, diagnostic solutions, and diabetes care. The company also provides hospital and consumer products, alongside innovative medical devices and molecular diagnostics, contributing to comprehensive human health solutions.

Recent filings

Filing Released Lang Actions
Re-Appointment of Chairman
Board/Management Information Classification · 90% confidence The document is a formal notice to the securities regulator and stock exchange informing them of the re-appointment of Mr. Ehsan Ali Malik as Chairman for a new term. It clearly announces a change in senior management (board-level appointment). This aligns with the definition of Board/Management Information (MANG).
2026-06-10 English
Re-Appointment of Chief Executive Officer
Board/Management Information Classification · 91% confidence The document is a formal announcement to the Securities & Exchange Commission and the Pakistan Stock Exchange informing of the re-appointment of the Chief Executive Officer. It clearly relates to a change in senior management rather than financial results, voting, or other topics. This corresponds to the Board/Management Information category.
2026-06-10 English
Dissemination of Video Recording Link of Corporate Briefing Session (CBS) 2026
Report Publication Announcement Classification · 80% confidence The document is a brief notice to the Pakistan Stock Exchange announcing the dissemination of a video recording link for a Corporate Briefing Session held on May 25, 2026. It does not include actual financial data or the presentation content itself, but simply announces where the material can be accessed. This fits the definition of a Report Publication Announcement (RPA).
2026-06-02 English
Revised Presentation of Corporate Briefing Session 2026
Investor Presentation Classification · 90% confidence The document is structured as a slide-style “Corporate Briefing Session” presentation with a Table of Contents, company overview, strategy, business performance, financial snapshots (statements, ratios, graphs), awards, outlook, and Q&A. It lacks formal audit language or regulatory headers, and is clearly an investor-focused slide deck rather than a formal annual or interim report. This matches the profile of an Investor Presentation (IP).
2026-05-25 English
Presentation of Corporate Briefing Session 2026
Investor Presentation Classification · 90% confidence The document is a slide‐style presentation labeled “Corporate Briefing Session” dated May 25, 2026, containing an overview of core values, history, multi‐year financial snapshots, strategic business segments, awards, future outlook, risks, and a Q&A section. It reads like an investor deck rather than a statutory report or regulatory announcement. There are no indications of a formal annual report filing, proxy statement, or earnings release; instead it is clearly a detailed investor presentation. Therefore, it should be classified as an Investor Presentation (IP).
2026-05-22 English
Corporate Briefing Session 2026
Regulatory Filings Classification · 72% confidence The document is a notice from Abbott Laboratories (Pakistan) Limited announcing a virtual Corporate Briefing Session to discuss the company’s year-ended financial performance, including meeting logistics and access details. It does not contain actual financial results, slide content, or a transcript, nor does it represent a formal report or filing type such as an annual/interim report, audit, or proxy statement. It is an event announcement of a non-regulatory type, falling under miscellaneous regulatory announcements. Therefore, the best match is Regulatory Filings (RNS).
2026-05-22 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.